NTLA
Price
$8.12
Change
-$0.16 (-1.93%)
Updated
May 9 closing price
Capitalization
857.67M
82 days until earnings call
TSHA
Price
$2.13
Change
+$0.03 (+1.43%)
Updated
May 9 closing price
Capitalization
430.61M
100 days until earnings call
Ad is loading...

NTLA vs TSHA

Header iconNTLA vs TSHA Comparison
Open Charts NTLA vs TSHABanner chart's image
Intellia Therapeutics
Price$8.12
Change-$0.16 (-1.93%)
Volume$5.14M
Capitalization857.67M
Taysha Gene Therapies
Price$2.13
Change+$0.03 (+1.43%)
Volume$2.13M
Capitalization430.61M
NTLA vs TSHA Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTLA vs. TSHA commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and TSHA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (NTLA: $8.12 vs. TSHA: $2.13)
Brand notoriety: NTLA and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 149% vs. TSHA: 82%
Market capitalization -- NTLA: $857.67M vs. TSHA: $430.61M
NTLA [@Biotechnology] is valued at $857.67M. TSHA’s [@Biotechnology] market capitalization is $430.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, both NTLA and TSHA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish while TSHA’s TA Score has 7 bullish TA indicator(s).

  • NTLA’s TA Score: 5 bullish, 4 bearish.
  • TSHA’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than NTLA.

Price Growth

NTLA (@Biotechnology) experienced а -8.14% price change this week, while TSHA (@Biotechnology) price change was -17.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

NTLA is expected to report earnings on Jul 31, 2025.

TSHA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($858M) has a higher market cap than TSHA($431M). TSHA YTD gains are higher at: 23.121 vs. NTLA (-30.360). TSHA has higher annual earnings (EBITDA): -87.95M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. TSHA (139M). TSHA has less debt than NTLA: TSHA (63.2M) vs NTLA (210M). NTLA has higher revenues than TSHA: NTLA (57.9M) vs TSHA (8.33M).
NTLATSHANTLA / TSHA
Capitalization858M431M199%
EBITDA-523.98M-87.95M596%
Gain YTD-30.36023.121-131%
P/E RatioN/A2.70-
Revenue57.9M8.33M695%
Total Cash602M139M433%
Total Debt210M63.2M332%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
9

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLATSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UNWPX1.89N/A
N/A
US Global Investors World Prec Mnral
PJRCX7.82N/A
N/A
PGIM Quant Solutions International Eq C
POVSX28.16N/A
N/A
Putnam International Equity A
ACSRX28.57N/A
N/A
Invesco Comstock R
VKSCX18.40N/A
N/A
Virtus KAR Small-Mid Cap Core C

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+1.43%
LOGC - TSHA
45%
Loosely correlated
-0.68%
SLDB - TSHA
42%
Loosely correlated
-0.36%
COGT - TSHA
41%
Loosely correlated
-3.41%
LRMR - TSHA
40%
Loosely correlated
-5.36%
NTLA - TSHA
39%
Loosely correlated
-1.93%
More